Figure 3.

Hematoxylin and eosin (H&E) staining and immunohistochemistry. H&E staining (×20) showed intracranial tumor (A), skeletal muscle infiltration (B), and skull invasion (C) Immunohistochemistry (×20) demonstrated diffuse GFAP positivity (D), S-100 positivity (E), IDH1 negativity (F), SSTR2 negativity (G), variable p53 positivity (weak to strong; H), and a Ki-67 labeling index of approximately 15% (I).